Trial Profile

Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alpha linolenic acid; Eicosapentaenoic acid; Eicosapentaenoic acid/docosahexaenoic acid
Indications Cardiovascular disorders; Postmyocardial infarction
Focus Therapeutic Use
Acronyms ALPHA OMEGA

20 Jul 2011 Data for effects on cognitive decline presented at the 2011 International Conference on Alzheimer's Disease.
31 Aug 2010 New trial record.
29 Aug 2010 Results have been presented at ESC Congress 2010: Annual Congress of the European Society of Cardiology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com